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Abstract
Objective : To compare the effectiveness of oxytocin dose 
of 10 IU and 20 IU for preventing uterine atony in women 
undergoing cesarean section.
Methods : This was a double-blind, randomized clinical trial 
with good matching selection with  randomization block of 
patients who had risk factors for the occurrence of uterine 
atony such as preeclampsia, patients were receiving MgSO4, 
oxytocin intrapartum and chorioamnionitis who performed 
stratifi ed randomization prospectively with two kinds of 
oxytocin doses which are 10 IU and 20 IU as a prophylaxis 
for uterine atony in women who performed emergency 
cesarean section with transverse incision and were using a 
general anesthesia.
Results : This study found no any signifi cant differences 
between the use of 10 IU and 20 IU as prophylaxis for uterine 
atony during cesarean section either in its action at the time 
or while in recovery room, especially on the cases without 
chorioamnionitis thus using oxytocin 10 IU regimen can be 
considered, besides the effectiveness did no differ, it will 
cost cheaper than oxytocin 20 IU regimen which frequently 
used.
Conclusions : There were no signifi cant differences in the 
incidence of blood loss during the cesarean section between 
the treatment of oxytocin 10 IU group and oxytocin 20 IU 
group. The additional uterotonic was using during the 
action of the cesarean section between the treatment of 
oxytocin 10 IU group, and oxytocin 20 IU group gave no 
signifi cant differences. The side effects in this study at least 
form of chills and vomiting found no signifi cant differences 
between both of groups despite the side effects that arise in 
oxytocin 20 IU group was higher at 23.08% than oxytocin 10 
IU group at 15.19%. Chorioamnionitis would be a risk factor 
for the occurrence of uterine atony during the action of the 
cesarean section if it associated with the use of additional 
uterotonic in oxytocin 10 IU group if compared with oxytocin 
20 IU group.
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Abstrak
Tujuan : Untuk membandingkan efektifi tas penggunaan 
dosis  10 IU dan 20 IU sebagai profi laksis atonia uteri pada 
saat seksio sesarea.
Metode : Penelitian ini menggunakan uji klinis acak  ganda 
dengan seleksi yang sesuai dengan blok  acak pada pasien-
pasien yang memiliki faktor risiko terjadinya atonia uteri 
seperti preeklamsia, pasien yang diberikana MgSO4 dan 
oxytocin intrapartum sebelumnya serta chorioamnionitis 
yang dilakukan pengacakan secara prosfektif bertingkat 
yang diberikan dua jenis dosis oksitosin yaitu 10 IU dan 20 
IU sebagai profi laksis atonia uteri pada perempuan yang 
dilakukan seksio sesarea darurat dengan insisi transversal 
dan menggunakan anestesi umum.
Hasil : Penelitian ini menemukan tidak adanya perbedaan 
yang bermakna antara penggunaan dosis oksitosin 10 
IU dan 20 IU sebagai profi laksis atonia uteri pada seksio 
sesarea baik saat tindakan operasi maupun  saat berada 
di ruang pemulihan, terutama pada kasus-kasus tanpa 
khorioamnionitis dimana memerlukan oksitosin tambahan 
pada kelompok 10 IU, selain efektifi tasnya tidak berbeda, 
akan lebih murah dari pada rejimen oksitosin 20 IU yang 
sering digunakan saat ini.
Kesimpulan : Berdasarkan hasil penelitian ini, tidak ada 
perbedaan yang bermakna dalam kejadian kehilangan darah 
selama operasi seksio sesarea antara perlakuan kelompok 
oksitosin 10 IU dan kelompok oksitosin 20 IU. Penggunaan 
uterotonik tambahan selama tindakan seksio sesarea antara 
perlakuan kelompok oksitosin 10 IU dan kelompok oksitosin 
20 IU tidak memberikan perbedaan yang signifi kan. Efek 
samping dalam penelitian ini yakni  menggigil dan muntah, 
tidak  ditemukan perbedaan yang bermakna antara kedua 
kelompok meskipun efek samping yang muncul pada 
kelompok oksitosin 20 IU lebih tinggi 23,08% dibandingkan 
kelompok oksitosin 10 IU pada 15,19%. Khorioamnionitis 
merupakan  faktor risiko terjadinya atonia uteri selama 
tindakan seksio sesarea jika dikaitkan dengan penggunaan 
uterotonika tambahan pada kelompok oksitosin 10 IU jika 
dibandingkan dengan kelompok oksitosin 20 IU.
Kata kunci : atonia uteri, oksitosin,  seksio sesarea.
INTRODUCTION
The labour is a culmination point of the human 
reproduction process by women after pregnancy 
over the course of time and a certain period. 
Postpartum haemorrhage is one of the leading 
causes of morbidity and mortality in mothers. 
In Indonesia, the causes of maternal death of 
mothers are haemorrhage (67%), infection (8%), 
toxaemia gravidarum (7%) and abortus (10%).1-3 
The cases of postpartum haemorrhage were 
mostly caused by uterine atony, which is about 
50 – 60% that can be prevented. The General 
Hospital Central Palembang, reported since 
1986–1989 of 12.476 deliveries with 67 maternal 
deaths are cases of haemorrhage 36,6% with 10% 
of them are caused by uterine atony.3
The postpartum haemorrhage is most often 
defi ned as a state of blood loss from 500 mL – 600 
mL in vaginal delivery during the fi rst 24 hours 
after birth and 1000 mL at delivery by cesarean 
section. Various risk factors have a signifi cance, 
by itself and by the combination that causing the 
bleeding postpartum, which are placenta previa, 
placental abruption, twin pregnancy, weight 
of birth is 4000 g or more, obesity, the kind of 
anesthesia that used, induction of labour, gave 
birth with an action, infection and obstacles 
in the progress of labour. Besides the vaginal 
laceration, the cause of bleeding commonly 
found is hypotonic myometrium.3-6
The existence of uterine atony has been thought 
would increase the postpartum haemorrhage. 
The uterine atony  is a signifi cant contribution 
to the occurrence of blood loss, especially after 
the action of cesarean section.4-5 Oxytocin has 
been widely used to prevent the uterine atony 
after childbirth.,7-12 The use of oxytocin, during 
the action of cesarean section to prevent uterine 
atony, is mostly based on experiences and only 
focus on vaginal delivery regimen guidance.
This study is meant to compare the 
effectiveness of oxytocin dose of 10 IU and 20 IU 
as prophylactic uterine atony in cesarean section. 
Comparing the incidences of bleeding that 
occurs, changes of hemoglobin level, hematocrit 
level and hemodynamic function and determine 
the use of additional uterotonic after treatment 
on both of oxytocin groups, to know the side 
effects that arise and identify the risk factors of 
uterine atony in the action of cesarean section 
against both of those oxytocin groups.
METHODS
This study was conducted with mothers 
that decided to deliver with an emergency 
transperitoneal cesarean section. Subjects were 
women with 22 weeks of pregnancy or more who 
went into labour.
Clinical Examination Methods
This study was using double-blind, randomized 
clinical trial with good matching selection with 
6 randomization block of patients who had risk 
factors for the occurrence of uterine atony such 
as preeclampsia, patients were receiving MgSO4, 
oxytocin intrapartum and chorioamnionitis who 
performed stratifi ed randomization prospectively 
with two kinds of oxytocin doses which are 
10 IU and 20 IU as prophylactic of uterine 
atony in women who underwent emergency 
transperitoneal cesarean section.
Laboratory Examination Methods
Measurement of haemoglobin concentration, 
hematocrit and leukocyte in units of g% for 
haemoglobin, vol% for hematocrit and mm3 for 
leukocyte with machine Cauter Mode DTH2 AS. 
Manufactured by Cauter Corporation. Avenue, 
Miami. USA.
Data Analyst
The variables studied were oxytocin 10 IU and 
20 IU , age, parity, birth weight, an indication of 
cesarean section, the amount of bleeding, the 
use of additional uterotonics (oxytocin, methyl 
ergotamine, misoprostol), duration of operating 
time, side effects, blood transfusions, blood 
pressure, pulse, temperature, hemoglobin and 
hematocrit level, the use of MgSO4, oxytocin 
intrapartum, clinical chorioamnionitis, duration 
of membrane rupture.
RESULT
Based on the statistical analysis, there were no 
differences in mean age in both groups (ρ> 
0.05).
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Table 1. Characteristic of the Subjects
Table 2. Characteristic Period, Blood Loss, Haemoglobin and Hematocrit Level
Characteristic
Characteristic Oxytocin 10 IU Oxytocin 20 IU mean ± SD
Age (years old)
29.39 ± 6.17
29.45 ± 5.74 29.42 ± 5.938*
Education
No School/not completed elementary
Elementary School
Junior High School
Senior High School
Academy
University
Occupation
No Job
Labor
Farmer
Trader
Private Employees
Government Employes
Address
City
Countryside
Gestational Age
Gestational Age (weeks)
Baby's Birth Weight
Birth Weight (g)
Period of the action of cesarean 
Duration of action (minutes)
Blood loss (mL)
The mean and the difference of 
haemoglobin level and hematocrit level
Haemoglobin before cesarean section
Haemoglobin after 24 hours
Differences in haemoglobin level
Hematocrit before cesarean section
Hematocrit after 24 hour
Differences in haematocrit level
57.512 ± 5.5777
475.51 ± 219.73
10
9
1
33.53 ± 4,580
30,14 ± 4,030
3.28 ± 3.14
58.0506 ± 6.6850
556.35 ± 330.37
33.40 ± 4,87
30.17 ± 4.22
3.35 ± 3.58
0.184
0.56
.876 ± 1.389
10.631 ± 1.541
0.599
.737 ± 1.275
9.582 ± 1.345
0.746
.054 ± 1.052
1.136 ± 0.988
0.298
0.532
7
25
15
19
9
4
41
2
8
7
9
12
52
27
39.14 ± 1.95
3199.36 ± 586.48
10.3
33.3
26.9
16.7
3.8
9.0
54.8
2.5
9.6
9.6
8.3
15.3
31.8
17.8
38.96 ± 1.57
3093.04 ± 623.56
0.242
0.335
8.9
31.6
19.0
24.1
11.4
5.1
51.9
2.5
10.1
8.9
11.4
15.2
33.1
17.2
8
26
21
13
3
7
43
4
7
8
4
12
50
28
Oxytocin 10IU
n%
Oxytocin 20IU
n%
Mean ± SD
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In this study, the mean gestational age was 
39.62  ± 0.948 weeks with the average age at 
oxytocin 10 IU group was 39.14 ± 1.95 weeks, and 
at oxytocin 20 IU group was 38.96 ± 1.57 weeks 
(p > 0.05). The youngest gestation was 28 weeks, 
and the oldest gestation was 43 weeks.
The mean of birth weight babies as a superfi cial 
mother that did the action of cesarean section in 
both of the groups was 3145.86  ±  605.926 g. The 
lightest birth weight of babies was 1600 g, and 
the heaviest was 4800 g. In this study showed no 
signifi cant differences of the mean of superfi cial 
birth weight of babies when the action of the 
cesarean section had done neither in oxytocin 10 
IU3199.36 ± 586.48 g nor oxytocin 20 IU 3093.04 
± 623.56 g (ρ> 0.05).
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Table 3. The Characteristics of Reproductive, Intrapartum, Indication C-section and Additional Uterotonic, Side Effect and 
Risk Factors.
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Characteristic
Reproductive Status
Nullipara
Multipara
Grandemultipara
Intrapartum Characteristics
MgSO₄ Intrapartum Oxytocin
Without Oxytocin
Induction
Acceleration
Chorioamnitis
Another Median of Rupture Membrane
Others
Indication C-section
CPD/FPD 
Fetal distress
Transverse lie
Neglected labour
Haemorhage antepartum
Others
The Use of Additional Uterotonic
Additional uterotonics
Oxytocin
Metilergometrin
Misoprostol
Side Effects
Chills
Vomiting
Total
Risk Factors
Neglected labour
MgSO₄ intrapartum
Oxytocin intrapartum
Chorioamnionitis
31 (39.7)
43 (55.1)
4 (5.1)
14 (17.7)
60 (75.9)
2 (2.5)
17 (21.5)
7 (8.9)
268.99 ± 455.37
5 (6.3)
15 (19.0)
8 (10.1)
4 (5.1)
32 (40.5)
15 (19.0)
5 (6.3)
34 (21.70)
28 (35.44)
7 (4.50)
-
8 (5.01)
4 (2.05)
12 (15.19)
11 (47.80)
7 (63.60)
19 (45.24)
8 (88.90)
27 (34.2)
49 (62.0)
3 (3.8)
11 (14.1)
55 (70,5)
5 (6,4)
18 (23.1)
8 (10.3)
300.90 ± 545.65
4 (5.1)
12 (15.4)
10 (12.8)
8 (10.3)
26 (33.3)
18 (23.1)
4 (5.1)
29 (18.50)
22 (28.51)
10 (6.40)
-
13 (8.03)
5 (3.02)
18 (23.08)
12 (52.20)
4 (36.40)
23 (54.76)
1 (11.10)
58 (36.9)
92 (58.6)
7 (4.5)
0.664
0.589
0.276
0.702
0.793
0.277
9 (5.7)
27 (17.2)
18 (11.5)
12(7.6)
58 (36.9)
33 (21.0)
9 (5.7)
0.279
0.351
0.453
-
0.250
0.746
0.260
0.930
0.278
0.001
Oxytocin 10 U
(%)
Oxytocin 20 U*
(%)
P-value
(%)
The mean of blood loss between both of treatment 
groups found no signifi cant differences, where 
oxytocin 10 IU group had 475.51 ± 219.73 mL, 
and oxytocin 20 IU group had 556.35 ± 330.37 
mL (ρ> 0.05) with the mean of blood loss between 
both of the groups were 515.67 ± 282.24 mL.
The mean of haemoglobin level before the 
action of cesarean section was 10.754 ± 1.4669 
g% with the lowest level about 5.5 g% and 
the highest level 15.7 g%, while the mean of 
hematocrit level was 33.46 ± 4.714 vol% with the 
lowest level of about 19  vol% and the highest 
level about 48 vol%.
In this study, the mean of haemoglobin level 
before the action of cesarean level, as well as 
24 hours after the action, found no signifi cant 
differences (ρ> 0.05) with the difference in oxytocin 
10 IU group was 1,054 ± 1.052 g%, and the mean 
of haemoglobin level was 0.820 ± 1.288  g%. In the 
oxytocin 20 IU group, the differences were 1.136 
± 0.988 g% with the mean of haemoglobin level 
0.912 ± 1.361 g%. The differences of hematocrit 
level in oxytocin 10 IU was 3,28 ± 3,14  vol%  with 
the mean of hematocrit level 2.58 ± 3.97 vol% 
and in oxytocin 20 IU was 3.35 ± 3.58 vol% with 
the mean of hematocrit level 2.54  ±  4.15 vol%.
The number of parity in this study varied 
from respondents who have never given birth 
before (nullipara), multipara: 1-5 times and 
grandmultipara: 6 times or more. The results 
found no signifi cant difference in mean parity of 
each group, which is 1.37 ± 1.85 times on oxytocin 
10 IU group and 1.53 ± 1.75 times on oxytocin 20 
IU group (ρ> 0.05).
The characteristic of intrapartum between 
both treatment groups was similar, that was 
*Chi Square Oxytocin 20 U : Þ>0.05
the patient who received MgSO4, oxytocin, the 
incident of chorioamnionitis and the duration 
of the membrane to be ruptured. This study 
found no signifi cant differences in intrapartum 
characteristics between both treatment groups 
(ρ> 0.05).
The most indication for the action of cesarean 
section was neglected labor 58 cases (36.9%) 
with 32 cases (40.5%) at oxytocin 10 IU group 
and 26 cases (33.3%) at oxytocin 20 IU group 
that was meant statistically found no signifi cant 
differences between both of treated groups (ρ 
= 0.877). Generally, statistical analysis found 
no signifi cant differences between both of the 
groups against the indication of cesarean section 
(ρ> 0.05). 
Oxytocin is the preparation that often used as 
an additional uterotonics in this study, about 28 
cases (35.44%) for oxytocin 10 IU and 22 cases 
(28.21%) for oxytocin 20 IU, followed by addition 
of methergine about 7 cases (4.5%) compared 
to 10 cases (6.4%) in each treatment groups. 
From statistically analysis found no signifi cant 
differences between both treatment groups 
against the use of additional uterotonics (ρ> 
0.05).
The use of additional uterotonics during the 
action of cesarean section is an action that given 
by an operator to avoid the uterine atony on 
patients in action so that the more of blood loss 
could be prevented because the operator could 
immediately assess and diagnose the contraction 
from uterine.
This results showed that both of the groups 
were needed additional uterotonics, so that 
found no signifi cant differences in both of them 
(ρ = 0.260). In cases that were used MgSO4 
intrapartum, from 25 cases about 11 cases of it 
(44%) need additional uterotonics with details, 
7 cases (63.6%) got additional uterotonics in 
oxytocin 10 IU group and 4 cases (36.4%) in 
oxytocin 20 IU group. The result of statistical 
analysis showed that MgSO4 intrapartum is not 
the signifi cant risk factor for uterine atony could 
happen (ρ = 0.93).
Like wise  the cases that got oxytocin 
intrapartum, either induction or acceleration, 
where from 42 cases that got oxytocin 
intrapartum, about 19 cases (45.24%) with 17 
cases (89.47%) of it accelerated at oxytocin 10 
IU group and 23 cases (54.76%) with 18 cases 
(78.26%) of it accelerated at oxytocin 20 IU. It 
found no signifi cant differences in risk factors 
for uterine atony on the cases that got oxytocin 
while intrapartum in both of treatment groups 
(ρ = 0.278), that means, in fact, the both of 
treatment groups almost the same, they require 
an additional uterotonic.
The interesting in this study, the cases with 
clinical chorioamnionitis diagnosis that got 
treatment of oxytocin 10 IU had signifi cant risk 
factors for occurrences the uterine atony, about 
16 cases with chorioamnionitis, 8 cases (88.9%) in 
oxytocin 10 IU and 1 case (11.1%) in oxytocin 20 
IU(ρ = 0.001).
The  changes of haemodynamics status 
assessed were: the changes of blood pressure 
systolic and diastolic, pulse, temperature and 
the changes in oxygen saturation before and 
after the action of the cesarean section. From 
statistical analysis found no signifi cant differences 
between the mean of haemodynamics status 
of respondents in both treatment groups both 
before and after the action of cesarean section 
(ρ>  0.05).
The side effects observed were allergy, 
diarrhoea, hypotension, chills, vomiting and others 
that might be caused by the use of oxytocin. In 
detail, the side effects that arose both treatment 
groups can be seen in the table below.
This study seems to reinforce the use of 
oxytocin preparation to prevent uterine atony in 
postpartum especially in the action of cesarean 
section, that commonly used in many countries 
because it is a safe drug and has no side effects 
on the heart if administered intravenously and 
continuously.
DISCUSSION
Based on the statistical analysis, found no 
signifi cant differences on the mean of age, that 
was  29.42  ± 5.938 years old in both of the 
treatment groups, in oxytocin 10 IU as well as 
oxytocin 20 IU (ρ> 0.05). Munn MB et al reported 
a mean of age of 25 ± 6 years old for low doses 
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of oxytocin 10 IU group and 25 ± 6  years old for 
high doses of oxytocin 80 U, meanwhile in who 
compared prostaglandin F2άwith oxytocin 20 IU 
got the mean of age was about 29.2 ± 5.9 years 
old for prostaglandin and 30.5 ± 3.8 years old for 
oxytocin group. Both studies showed that they 
had no signifi cant differences in the mean of 
ages; this result is the same as the result of this 
study.12,13
The number of parity in this study varied from 
respondents who never give birth (nullipara), 
multipara: 1 – 5 times and grand multipara: 6 
times or more. A number of parity counted based 
on the history of labour ever experienced at 
gestational age above 22 weeks.2 In this study the 
mean of parity in both of the treatment groups 
was  1.45 ± 1.795 times with range 0 to 9 with the 
reproductive status of respondents mostly was 
multipara about 92 cases (58.6%) with 43 cases 
(55.1%) on oxytocin 10 IU group and 49 cases 
(62%) on oxytocin 20 IU group. This study found 
no signifi cant differences at the mean of parity in 
each group, that was about 1,37 ± 1,85 times on 
oxytocin 10 IU group and 1.53 ± 1.75 times on 
oxytocin 20 IU group (ρ> 0,05). The result had no 
differ much compared to results that obtained by 
Dansereau et al, who compared carbetocin (1,2 
± 0,8) with Oxytocin (1,2 ± 0,9) in the action of 
cesarean section.10
The mean of gestational age was 39.62  ± 0.948 
weeks, in oxytocin 10 IU group was about 39.14 
± 1.95 weeks, and in oxytocin 20 IU was about 
38.96 ± 1.57 weeks. The youngest gestational age 
was 28 weeks, and the oldest was 43 weeks. From 
the result, the mean of gestational age between 
both treatment groups found no signifi cant 
differences (ρ> 0.05). The gestational age was 37 
±  4.3 weeks in oxytocin with low doses group 
and 37 ± 4.9 weeks in high doses group, while 
got the result that did not much difference in this 
study, that was 38.4 ± 0.9 weeks in oxytocin 20 
IU group and the comparison group was 38.5 ± 
0.8 weeks.12
The mean birth weight babies as superfi cial of 
mothers that had an action of cesarean section 
in both of the groups were 3145.86 ± 605.926 
g. In this study showed no signifi cant differences 
of the mean of superfi cial birth weight babies in 
action of cesarean section are performed, either 
in oxytocin 10 IU group was about 3199,36 ± 
586,48 g or in oxytocin 20 IU group was 3093.04 ± 
623.56 g (ρ> 0.05). The mean birth weight babies 
were 3284 ± 367 g for oxytocin 20 IU group and 
about 3139 ± 461 g for PGF2α group.12
The mean of cesarean section duration was 
about 57.7834 ± 6.1460 minutes, treatment with 
dose oxytocin 10 IU group 57.51228 ±  5.5777 
minutes and oxytocin 20 IU group 58.0506 ± 
6,6850 minutes, with the range time of cesarean 
section between 45 to 75 minutes. From the 
statistical analysis found no signifi cant differences 
between both of the treatment groups in duration 
of action (ρ> 0,05). This duration is less with the 
mean of duration of action for each treatment 
groups was similar, that was 52 ± 16 minutes on 
low dose and 54 ± 18 minutes on high dose(ρ = 
0.53) and got the mean was about 45,1 minutes in 
20 IU group and 47.5 minutes in the comparison 
groups.12,13
The indication to perform an emergency 
action of cesarean section include DKP or FPD, 
fetal distress, HAP (placenta previa and placental 
abruption), neglected labour and abnormalities 
position of babies as well as other indications 
such as a history of cesarean section twice as 
much as 8 cases, each treatment group were 4 
cases and six years of primary infertility was 1 
case in oxytocin 10 IU group. The indications that 
the most took an action of cesarean section were 
neglected labour about 58 cases (36.9%) with 
32 cases (40.5%) in oxytocin 10 IU group and 26 
cases (33.3%) in the oxytocin 20 IU group, which 
means in statistical analysis found no signifi cant 
differences between both treatment groups (ρ = 
0,877). The result was the same as that obtained 
where the most indication of cesarean section 
caused by neglected labor, was 41% for oxytocin 
with low dose and 34% for another (ρ = 0,16) 
and different with the result that obtained where 
the most indication was the former of cesarean 
section about 66.67% in oxytocin 20 IU group 
and 50% in the comparison group.12,13
The Intrapartum characteristics of both 
treatment groups are almost the same. 
No signifi cant differences for intrapartum 
characteristics between both treatment groups 
(ρ> 0.05). This result was the same, but this study 
did not have amnioinfusion characteristics as they 
had obtained as 19% for a low dose of oxytocin 
and 23% for high dose because this procedure 
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was not the routine procedure that held in this 
department.13
The mean of blood loss between both treatment 
groups found no signifi cant differences, with the 
mean of blood loss between both of the groups 
was 515.67 ± 282.24 mL(ρ> 0.05). This result 
was the same although the mean of bleeding 
between both of treatment groups in this study 
was less than they have obtained, that was about 
957 ± 148 mL in oxytocin with a low dose and 
937 ± 159 mL (ρ = 0.08). The haemoglobin and 
hematocrit level was the critical variable to assess 
the blood loss in this study. In this study, obtained 
the mean of haemoglobin level before the action 
of cesarean section was 10.754 ± 1.4669 g% 
with the lowest 5.5 g% and the highest 15.7 g%, 
while the mean of hematocrit level was 33.46 ± 
4.714 vol%, with the lowest was 19  vol% and the 
highest was 48 vol%. In this study, the mean of 
haemoglobin level before the action of cesarean 
section and 24 hours after the action of cesarean 
section showed no signifi cant differences (ρ> 
0.05).
Haemoglobin and hematocrit level in 
statistically had no signifi cant differences 
showed that the infl uence of haemoglobin and 
hematocrit level as a causal factor to success and 
failure in preventing of bleeding in the cesarean 
section could be ignored in both of the groups 
in this study. In this study, the mean of blood 
loss and decreasing hematocrit level found no 
differences between both treatment groups. It 
was predicted because uterine atony is easily 
diagnosed and treated at the time the action 
of the cesarean section took place because the 
uterus was exposed and more easily evaluated 
than vaginal deliveries. This situation will facilitate 
the introduction, and prompt treatment with the 
use of additional uterotonic thus would reduce 
the blood loss more.
Reduction, the amount of blood loss during 
the action of the cesarean section, was benefi cial 
for patients that could reduce morbidity and 
the need for blood transfusion after the action. 
Although an accurate determination of blood 
loss required at the time of surgery, it was very 
challenging to do, especially inaction of the 
cesarean section because of the infl uence of the 
amniotic fl uid and meconium. Blood loss less 
than 500 mL during the action of the caesarean 
section could still be considered the accurate, but 
if more of it would be diffi cult to estimate the 
blood loss.10This study realized the diffi culties, 
but the double-blind, randomized clinical trial 
has reduced bias in assessing blood loss and this 
study also compared the change in haemoglobin 
and hematocrit level.
Oxytocin is a preparation that is often used 
as an additional uterotonic in this study, based 
on the statistical analysis found no signifi cant 
difference between both of the treatment groups 
against the use of additional uterotonic (ρ> 
0.05). These results differ from previous studies 
obtained which is as much as 39% in small doses 
of oxytocin 10 IU versus 19% on large doses of 80 
U (ρ<0.01, RR 2.1 95% CI, .4, 3).13
More widespread use of oxytocin as an 
additional uterotonic in this study, when 
compared to other types of uterotonic, seems 
to correspond with the function of oxytocin as 
fi rst-line preparation to prevent postpartum 
haemorrhage. The absence of the addition of 
misoprostol during surgery, this might be related 
to the way of this preparation was less practical 
during the action of the cesarean section. There 
were 4 cases the addition of methergine as a 
second line of uterotonic after adding oxytocin 
to prevent the persistent uterine atony. There 
was no discontinuation solution case study 
because of complications during the action of the 
cesarean section. More on this study, obtained in 
recovering rooms the additional uterotoniceach 
oxytocin 10 IU group: methergine. These results 
indicated that the need for additional uterotonic in 
recovering room between both treatment groups 
was not much different. In this study, changes 
in hemodynamic status were assessed include 
changes in systolic and diastolic blood pressure, 
pulse, temperature and the changes in oxygen 
saturation before and after cesarean section. 
From a statistical analysis showed no signifi cant 
difference between the mean haemodynamic 
status of respondents between both treatment 
groups before and after the action of cesarean 
section (ρ> 0.05).
Obtained the minimal side effects, so there 
was no termination solution for the study due to 
side effects. Hypotension and water intoxication 
were often feared the clinicians due to the use 
of oxytocin in this study was not found. There 
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were no signifi cant differences between the side 
effects that arise (chills and vomiting) in both 
of treatment groups (ρ> 0.05), although the 
incidence of adverse events was slightly higher 
in the group of 20 IU (23.08%) compared to the 
group of 10 IU (15.19% ). From this research 
seems to reinforce the use of preparations of 
oxytocin to prevent postpartum uterine atony 
at cesarean section, especially when the action 
that has been widely used in many countries 
as it is a safe drug and has no side effects on 
the heart when administered intravenously and 
continuously. This drug has been recommended 
in various studies and writings with its use as 
an isotonic solution simultaneously antidiuretic 
effect and the possibility of hyponatremia.
In this study, patients who experience such 
disruption labour progress were required the 
additional uterotonic at oxytocin 10 IU group 
(47.8%) and in oxytocin 20 IU group (52.2%). 
The results indicate both of groups is almost 
the same that was needadditional uterotonic 
preparation so that there were no signifi cant 
differences between both treatment groups 
(ρ = 0,260). These results differ from the study 
those obtained in which the ratio of 41% was 
obtained at 10 IU oxytocin group and 22% in 
the comparison group (ρ = 0,001). In cases with 
the use of intrapartum MgSO4, 44,00% of them 
required an additional uterotonic atoxytocin 10 
IU group (63,60%) and the oxytocin 20 IU group 
(36.40%). From the statistical analysis, it turned 
MgSO4intrapartumwas not a signifi cant risk factor 
for the occurrence of uterine atony, (ρ = 0,93). 
These results were the same as those obtained 
which was 32% versus 29% (ρ = 0,57).13
Likewise with cases that got intrapartum 
oxytocin, either induction or acceleration. There 
were no signifi cant differences in risk factors for 
the occurrence of uterine atony in cases that got 
oxytocin when intrapartum in both of treatment 
groups (ρ = 0.278) in the sense that almost 
the same both of treatment groups required 
additional uterotonic. The interesting thing about 
this study, it turns out the cases with a diagnosis of 
clinical chorioamnionitis who received treatment 
oxytocin 10 IU proved to have a signifi cant risk 
factor for the occurrence of uterine atony, as 
much as 88.9% and 11.1% in the group treated 
with oxytocin 20 IU ( ρ = 0.001). These results 
were obtained from studies  in which a low dose 
of 10 IU treatment was more need for additional 
uterotonic in emergency action of cesarean 
section when compared with high-dose oxytocin 
(50% versus 24% with ρ> 0.001).13
CONCLUSION
Referring to the results of this study, which is not 
found signifi cant differences between the use 
of oxytocin 10 IU and 20 IU as prophylactic of 
uterine atony  on the actions of cesarean section 
either at the time the action caesarean section as 
well as in the recovery room, especially in cases 
without chorioamnionitis, then the use of regimen 
oxytocin 10 IU could be considered, in addition to 
its effectiveness did not differ, the cost of which 
will be paid half cheaper when compared to the 
regimen of 20 IU which has been frequently used. 
The results of this study ultimately expected to 
be a recommendation on the use of oxytocin 
as prophylaxis of uterine atony during cesarean 
section in obstetric practice every day.
The use of uterotonic preparations should still 
be used to prevent uterine atony and reduced 
bleeding duringcesarean section. Oxytocin 
regimen of 10 IU can be considered to be the 
fi rst line as prophylaxis for uterine atony during 
cesarean section, especially in those without 
chorioamnionitis.
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